Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above

BMC Infectious Diseases

Table 2 Estimated LSMeans EQ-5D utility scores and EQ-5D VAS scores over 3 months by age group

Day	50–59 y N = 142		60–64 y N = 59		65–69 y N = 67		70–79 y N = 182		≥ 80 y N = 63		All N = 513
	LSMean	SE	LSMean	SE	LSMean	SE	LSMean	SE	LSMean	SE	LSMean	SE
EQ-5D utility scores
0	0.768	0.024	0.704	0.037	0.758	0.034	0.725	0.021	0.733	0.036	0.740	0.012
15	0.829	0.022	0.786	0.034	0.779	0.032	0.778	0.019	0.707	0.033	0.785	0.012
30	0.898	0.017	0.880	0.026	0.864	0.024	0.845	0.015	0.782	0.026	0.859	0.009
60	0.954	0.012	0.923	0.019	0.936	0.017	0.913	0.011	0.864	0.019	0.922	0.006
90	0.959	0.010	0.963	0.016	0.949	0.016	0.942	0.009	0.871	0.016	0.942	0.006
EQ-5D VAS scores
0	61.0	2.1	58.7	3.1	59.3	2.9	61.0	1.8	58.3	3.1	60.2	1.1
15	70.7	1.9	65.7	3.0	64.9	2.7	62.8	1.7	59.7	2.8	65.2	1.0
30	76.5	2.0	73.2	3.0	72.5	2.9	69.0	1.7	69.3	3.0	72.1	1.0
60	85.8	1.8	80.7	2.8	84.1	2.6	80.1	1.6	77.0	2.7	81.9	0.9
90	88.9	1.7	85.5	2.7	87.2	2.5	86.1	1.5	81.2	2.6	86.4	0.9

LS least square, HZ herpes zoster, EQ-5D EuroQoL five-dimension scale, VAS visual analog scale, N total number in each age group, SE standard error, y years old

ISSN: 1471-2334